Wohlschlager, T., Scheffler, K., Forstenlehner, I. C., Skala, W., Senn, S., Damoc, E., . . . Huber, C. G. (2018). Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals. Nat Commun.

Wohlschlager, Therese, Kai Scheffler, Ines C. Forstenlehner, Wolfgang Skala, Stefan Senn, Eugen Damoc, Johann Holzmann, a Christian G. Huber. "Native Mass Spectrometry Combined With Enzymatic Dissection Unravels Glycoform Heterogeneity of Biopharmaceuticals." Nat Commun 2018.

Wohlschlager, Therese, et al. "Native Mass Spectrometry Combined With Enzymatic Dissection Unravels Glycoform Heterogeneity of Biopharmaceuticals." Nat Commun 2018.